Skip to main content
Erschienen in: Child's Nervous System 1/2016

Open Access 01.01.2016 | Case Report

Intradural prepontine chordoma in an 11-year-old boy. A case report

verfasst von: R. Saman Vinke, Elise Charlotte Lamers, Benno Kusters, Erik J. van Lindert

Erschienen in: Child's Nervous System | Ausgabe 1/2016

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Case report

The authors report a case of an 11-year-old boy that presented with headache and vomiting that was present for several months. CT and MR imaging revealed a large prepontine mass and an obstructive hydrocephalus. A ventriculoperitoneal shunt was inserted, and in a second operation, a radiologically proven total resection was performed, using a left frontotemporal transsylvian approach. The tumour showed no involvement of the dura or clivus. Histological examination showed the characteristics of a chordoma. No further adjuvant treatment was given. The patient remained disease or tumour free after a 6-year follow-up.

Discussion

Intradural chordomas are extremely rare tumours that originate from notochordal remnants. Only three other cases have been reported in the paediatric population. Ecchordosis physaliphora (EP) is an ectopic notochordal remnant that has a similar biological behaviour and is difficult to distinguish from intradural chordomas. They might exist in a continuum from benign notochordal tumour to malignant chordoma. A surgical resection without adjuvant radiation therapy is suggested to be the treatment of choice in the paediatric population.

Conclusion

The authors describe a rare case of an intradural prepontine chordoma in an 11-year-old boy that stayed disease free after a 6-year follow-up.

Introduction

Chordomas are rare, slow-growing tumours accounting for 1–4 % of all primary malignant bone tumours [11]. They usually occur in adults with a peak incidence between 50 and 60 years of age [16]. The incidence in children and adolescents is less than 5 % of the total incidence [4]. Chordomas are thought to arise from notochordal remnants throughout the axial skeleton and are most commonly located in the skull base, mobile spine and sacrum at an almost equal distribution [16]. Although intradural localization of chordomas is rare, several cases have been reported in the literature. However, most of the reported cases have occurred in adults and only three cases of a pure intradural chordoma in a paediatric patient have been reported [5, 9, 27]. In this report, we present a case of an intradural prepontine chordoma in an 11-year-old boy with a 6-year follow-up and an update of the literature.

Case report

An 11-year-old boy presented with a history of headaches and vomiting that had been present for several months. Physical examination showed papilledema without the presence of any other neurological deficits. Magnetic resonance imaging (MRI) revealed a large prepontine mass with dorsal displacement of the brainstem and a secondary obstructive hydrocephalus due to compression of the aqueduct. The lesion had an inhomogeneous hypointense aspect on the T1-weighted image (T1WI) and an inhomogeneous hyperintense aspect on the T2-weighted image (T2WI). After administration of IV gadolinium, there was some inhomogeneous enhancement (Fig. 1). Computed tomography (CT) imaging showed no bone involvement.

Operation

During the first operation, a ventriculoperitoneal shunt was inserted into the right lateral ventricle to treat the hydrocephalus. A careful study of the MRI suggested that this infra- and supratentorially located tumour might be resected through a single approach. A left frontotemporal transsylvian approach was performed to gain access to the tumour. The tumour had well-defined margins and was entirely located in the intradural plane. There were no attachments to the cranial nerves or brainstem. A macroscopic complete resection was performed.

Postoperative course

Postoperatively, the patient had developed a left oculomotor nerve palsy, which completely recovered within the next 4 weeks. The postoperative MRI showed a complete removal of the tumour (Fig. 2). After careful consideration by a multidisciplinary team, we decided that there was no indication for postoperative radiation therapy. At follow-up one and a half years later, the patient was found to have remained asymptomatic. There were no signs of tumour recurrence on the MRI scan. At a follow-up of more than 6 years after treatment, there were still no signs of tumour recurrence on the MRI scan.

Histopathological and immunohistochemical findings

Histological examination showed a slightly lobulated tumour consisting of a chondromyxoid matrix. The tumour cells showed a vacuolated and pale cytoplasm. Moderate nuclear polymorphism was observed but no obvious mitotic activity (Fig. 3). Some calcifications were seen. The tumour cells stained positive for pan-keratin, S-100 and epithelial membrane antigen (EMA). These findings suggest a histopathological diagnosis of chordoma.

Discussion

Chordomas are rare primary bone tumours. Despite their low-grade histological characteristics, chordomas often show a malignant disease course [2, 21, 23]. Symptoms usually develop gradually, related to the relatively slow-growing tumour compressing the surrounding structures. However, chordomas can present with acute and progressive clinical symptoms due to intratumoral haemorrhage as well [22]. The extent of initial surgical resection has been shown to be the most important predictor of local tumour recurrence and long-term survival [6, 10, 14, 23].
Chordomas are most commonly located in the extradural space, with possible transdural progression. Purely intradurally localised chordomas are extremely rare with an incidence of 3.8 % of all chordoma cases. Nevertheless, several cases and even small case series have been reported in the literature [3, 20, 24]. To our knowledge, only three other cases of intradural chordoma have been reported in the paediatric population (Table 1).
Table 1
Reported cases of intradural chordomas in the paediatric population
Reference
Age (years)
Sex
Location
Resection
RTx
Follow-up
Recurrence
Dow et al. (2003) [9]
9
F
Right cerebellar hemisphere
Complete
No
14 months
No
Chang et al. (2008) [5]
9
M
Right prepontine cistern
Complete
No
12 months
No
Zhang et al. (2010) [27]
8
ND
ND
ND
ND
ND
ND
This case
11
M
Prepontine
Complete
No
6 years
No
RTx radiotherapy, ND no data available
Intradural chordomas tend to show different biological behaviour compared to classic chordomas. In contrast to classic chordomas, purely intradural chordomas seem to have well-defined tumour margins, do not show bone invasion and are less adhesive to the surrounding structures all of which improves the resectability [20]. This is likely to be a reason for the lower recurrence rate compared to typical chordomas. In the literature, several cases of intradural chordomas are reported in children and adults (for review, see Dow et al. [9] and Masui et al. [15]). None of the reported cases showed tumour recurrence after surgery, even in cases of subtotal resection. In contrast, typical chordomas often show recurrence, metastatic features and progression to death despite adequate surgical resection, which is sometimes followed by adjuvant radiation therapy or chemotherapy [12]. However, AlOtaibi et al. [1] suggest in a recent systematic review that in the adult population, intradural chordomas show a comparable biological behaviour to typical cranial base chordomas.
Chordomas are thought to originate from remnants of the embryological notochord throughout the axial skeleton. Whereas typical chordomas are localised extradurally with possible transdural progression, this pathophysiologic mechanism does not explain a purely intradural localisation of chordomas.
Ecchordosis physaliphora (EP) are ectopic notochordal remnants that are usually asymptomatic. An incidence of 1.5–2 % in autopsy studies and approximately 1.7 % in MRI studies has been found [8, 17, 19]. EPs are typically found in the prepontine cistern, attached to the dorsal clivus with a small pedicle [13, 25]. Other distinctive features are that EPs generally occur in younger people compared to intradural chordomas and that EPs show no enhancement after gadolinium administration on MR imaging, whereas intradural chordomas show a variable enhancement [7, 17]. Although differentiating between symptomatic EPs and intradural chordomas based on histology is difficult and debated, Yamaguchi et al. [26] suggested some histological differentiating features. Symptomatic EPs and intradural chordomas tend to show a similar benign behaviour with a very low risk of tumour recurrence after surgical resection [7]. Chang et al. [5] suggest that EPs and intradural chordomas exist in a continuum from benign hamartomas to aggressive typical chordomas.
Treatment of a classic chordoma involves extensive surgery, sometimes combined with adjuvant radiation therapy [23]. There is not enough data available to postulate an evidence-based treatment for intradural chordomas in the paediatric population. One should consider that all of the reported cases (Table 1) were treated with a complete surgical resection without any adjuvant treatment, and none of these tumours did reoccur. Even cases in adults treated with a subtotal resection without adjuvant therapy did not show tumour recurrence after a 5-year follow-up [18]. Therefore, the role of adjuvant radiation therapy for intradural chordomas is debated. Considering the potential deleterious effect on the paediatric brain, radiation therapy should be avoided in the paediatric population. The authors postulate that a complete surgical resection without adjuvant radiation therapy should be the treatment of choice.

Conclusion

Although extremely rare, an intradural chordoma should be considered in the differential diagnosis of intradural prepontine lesions. The authors postulate that a complete surgical resection without adjuvant radiation therapy is the treatment of choice and that adjuvant radiation therapy should be avoided in the paediatric population. Additional studies are required to improve our knowledge about intradural chordomas and their treatment.

Disclosure

The authors report no conflicts of interest.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

e.Med Neurologie

Kombi-Abonnement

Mit e.Med Neurologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes, den Premium-Inhalten der neurologischen Fachzeitschriften, inklusive einer gedruckten Neurologie-Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
2.
Zurück zum Zitat Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM (2000) Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 88:2122–2134CrossRefPubMed Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Meis-Kindblom JM (2000) Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 88:2122–2134CrossRefPubMed
3.
Zurück zum Zitat Bergmann M, Abdalla Y, Neubauer U, Schildhaus HU, Probst-Cousin S (2010) Primary intradural chordoma: report on three cases and review of the literature. Clin Neuropathol 29:169–176CrossRefPubMed Bergmann M, Abdalla Y, Neubauer U, Schildhaus HU, Probst-Cousin S (2010) Primary intradural chordoma: report on three cases and review of the literature. Clin Neuropathol 29:169–176CrossRefPubMed
6.
Zurück zum Zitat Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson Jr RC (1999) Lumbosacral chordoma. Prognostic factors and treatment. Spine (Phila Pa 1976) 24:1639–1645CrossRef Cheng EY, Ozerdemoglu RA, Transfeldt EE, Thompson Jr RC (1999) Lumbosacral chordoma. Prognostic factors and treatment. Spine (Phila Pa 1976) 24:1639–1645CrossRef
8.
Zurück zum Zitat Congdon CC (1952) Benign and malignant chordomas; a clinico-anatomical study of twenty-two cases. Am J Pathol 28:793–821PubMedCentralPubMed Congdon CC (1952) Benign and malignant chordomas; a clinico-anatomical study of twenty-two cases. Am J Pathol 28:793–821PubMedCentralPubMed
9.
11.
Zurück zum Zitat Healey JH, Lane JM (1989) Chordoma: a critical review of diagnosis and treatment. Orthop Clin N Am 20:417–426 Healey JH, Lane JM (1989) Chordoma: a critical review of diagnosis and treatment. Orthop Clin N Am 20:417–426
12.
Zurück zum Zitat Kaneko Y, Sato Y, Iwaki T, Shin RW, Tateishi J, Fukui M (1991) Chordoma in early childhood: a clinicopathological study. Neurosurgery 29:442–446CrossRefPubMed Kaneko Y, Sato Y, Iwaki T, Shin RW, Tateishi J, Fukui M (1991) Chordoma in early childhood: a clinicopathological study. Neurosurgery 29:442–446CrossRefPubMed
14.
Zurück zum Zitat Kayani B, Sewell MD, Hanna SA, Saifuddin A, Aston W, Pollock R, Skinner J, Molloy S, Briggs TW (2014) Prognostic factors in the operative management of dedifferentiated sacral chordomas. Neurosurgery. doi:10.1227/NEU.0000000000000423 PubMed Kayani B, Sewell MD, Hanna SA, Saifuddin A, Aston W, Pollock R, Skinner J, Molloy S, Briggs TW (2014) Prognostic factors in the operative management of dedifferentiated sacral chordomas. Neurosurgery. doi:10.​1227/​NEU.​0000000000000423​ PubMed
15.
Zurück zum Zitat Masui K, Kawai S, Yonezawa T, Fujimoto K, Nishi N (2006) Intradural retroclival chordoma without bone involvement—case report. Neurol Med Chir 46:552–555CrossRef Masui K, Kawai S, Yonezawa T, Fujimoto K, Nishi N (2006) Intradural retroclival chordoma without bone involvement—case report. Neurol Med Chir 46:552–555CrossRef
16.
Zurück zum Zitat McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 12:1–11CrossRefPubMed McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control 12:1–11CrossRefPubMed
17.
Zurück zum Zitat Mehnert F, Beschorner R, Kuker W, Hahn U, Nagele T (2004) Retroclival ecchordosis physaliphora: MR imaging and review of the literature. AJNR Am J Neuroradiol 25:1851–1855PubMed Mehnert F, Beschorner R, Kuker W, Hahn U, Nagele T (2004) Retroclival ecchordosis physaliphora: MR imaging and review of the literature. AJNR Am J Neuroradiol 25:1851–1855PubMed
19.
Zurück zum Zitat Ribbert H (1904) Geschwulstlehre für Aerzte und Studierende. F. Cohen, Bonn Ribbert H (1904) Geschwulstlehre für Aerzte und Studierende. F. Cohen, Bonn
21.
Zurück zum Zitat Schwab JH, Boland PJ, Agaram NP, Socci ND, Guo T, O'Toole GC, Wang X, Ostroumov E, Hunter CJ, Block JA, Doty S, Ferrone S, Healey JH, Antonescu CR (2009) Chordoma and chondrosarcoma gene profile: implications for immunotherapy. Cancer Immunol Immunother 58:339–349. doi:10.1007/s00262-008-0557-7 CrossRefPubMedCentralPubMed Schwab JH, Boland PJ, Agaram NP, Socci ND, Guo T, O'Toole GC, Wang X, Ostroumov E, Hunter CJ, Block JA, Doty S, Ferrone S, Healey JH, Antonescu CR (2009) Chordoma and chondrosarcoma gene profile: implications for immunotherapy. Cancer Immunol Immunother 58:339–349. doi:10.​1007/​s00262-008-0557-7 CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Uda T, Ohata K, Takami T, Hara M (2006) An intradural skull base chordoma presenting with acute intratumoral hemorrhage. Neurol India 54:306–307CrossRefPubMed Uda T, Ohata K, Takami T, Hara M (2006) An intradural skull base chordoma presenting with acute intratumoral hemorrhage. Neurol India 54:306–307CrossRefPubMed
25.
Zurück zum Zitat Wolfe 3rd JT, Scheithauer BW (1987) “Intradural chordoma” or “giant ecchordosis physaliphora”? Report of two cases. Clin Neuropathol 6:98–103PubMed Wolfe 3rd JT, Scheithauer BW (1987) “Intradural chordoma” or “giant ecchordosis physaliphora”? Report of two cases. Clin Neuropathol 6:98–103PubMed
26.
Zurück zum Zitat Yamaguchi T, Suzuki S, Ishiiwa H, Shimizu K, Ueda Y (2004) Benign notochordal cell tumors: a comparative histological study of benign notochordal cell tumors, classic chordomas, and notochordal vestiges of fetal intervertebral discs. Am J Surg Pathol 28:756–761CrossRefPubMed Yamaguchi T, Suzuki S, Ishiiwa H, Shimizu K, Ueda Y (2004) Benign notochordal cell tumors: a comparative histological study of benign notochordal cell tumors, classic chordomas, and notochordal vestiges of fetal intervertebral discs. Am J Surg Pathol 28:756–761CrossRefPubMed
27.
Zurück zum Zitat Zhang QH, Kong F, Guo HC, Chen G (2010) Nasal endoscopic resection of extended intradural clival chordoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 45:542–546PubMed Zhang QH, Kong F, Guo HC, Chen G (2010) Nasal endoscopic resection of extended intradural clival chordoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 45:542–546PubMed
Metadaten
Titel
Intradural prepontine chordoma in an 11-year-old boy. A case report
verfasst von
R. Saman Vinke
Elise Charlotte Lamers
Benno Kusters
Erik J. van Lindert
Publikationsdatum
01.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Child's Nervous System / Ausgabe 1/2016
Print ISSN: 0256-7040
Elektronische ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-015-2818-z

Weitere Artikel der Ausgabe 1/2016

Child's Nervous System 1/2016 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.